[Correction of immunologic disorders in patients with burns].
Addition of immunomodulating therapy with Thymalin, a thymus agent, to the multimodality therapy of burnt patients contributes to a rapid normalization of immunological parameters. The most marked immune response was observed 7-10 days after a therapy course initiated in the early periods of burn disease in patients with severely depressed T-system immunity and a high sensitivity to the drug. Inclusion of a donor blood leukomass transfusion course activates the cellular link of the immune system just after the treatment course, but fails to favour a stable normalization of thymus-dependent lymphocyte ratios.
Shkrob
L O
LO
Lukoianova
T N
TN
Vishnevskaia
S M
SM
Panova
Iu M
IuM
Kashin
Iu D
IuD
D000276:Adjuvants, Immunologic; D000293:Adolescent; D000328:Adult; D000368:Aged; D001803:Blood Transfusion; D002056:Burns / Q000276:immunology* / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D007958:Leukocyte Count; D008231:Lymphopenia / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D008875:Middle Aged; D013601:T-Lymphocytes / Q000276:immunology*; D013951:Thymus Hormones / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D013951:Thymus Hormones; C032805:thymalin
Korrektsiia immunnykh narusheniĭ u bol'nykh ozhogovoĭ bolezn'iu.